Innovations in melanoma genetics;Novedades en genética del melanoma

Piel

Volumn 21, Issue 6, 2006, Pages 272-274

  Puig, Susana ^a   Anton Puig Butille, Joan ^a   Badenas, Celia ^a   Cuellar, Francisco ^a,b   Malvehy, Josep ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b Jalisco   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69549151817     PISSN: 02139251     EISSN: 15788830     Source Type: Journal    
DOI: 10.1016/S0213-9251(06)72488-1     Document Type: Article

References (24)

1. M. Berwick, B.K. Armstrong, L. Ben-Porat, J. Fine, A.l. Kricker, and C. Eberle et al. Sun Exposure and Mortality From Melanoma J Natl Cancer Inst 3 1997 195 199
2. J.K. Rivers Is there more than one road to melanoma? Lancet 363 2004 728 730
3. M. Serrano, G.J. Hannon, and D. Beach A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 1993 704 707
4. H. Rizos, S. Puig, C. Badenas, J. Malvehy, A.P. Darmanian, and L. Jimenez et al. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF Oncogene 20 2001 5543 5547
5. D.T. Bishop, F. Demenais, A.M. Goldstein, W. Bergman, J. Newton Bishop, and B. Bressac Paillerets et al. Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma J. Natl Cancer Inst 94 2002 894 903
6. A. Ruiz, S. Puig, J. Malvehy, C. Lazaro, M. Lynch, and A.M. Giménez-Arnau et al. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia J Med Genet 36 1999 490 493
7. P. Ciotti, J.P. Struewing, M. Mantelli, A. Chompret, M.F. Avril, and P.L. Santi et al. A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families Am J Hum Genet 67 2000 311 319
8. E. Yakobson, E. Shlomit, R. Isacson, D. Halle, E. Levylahad, and R. Catane et al. A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families Eur J Hum Genet 11 2003 288 296
9. S. Puig, J. Malvehy, C. Badenas, A. Ruiz, D. Jiménez, and F. Cuellar et al. Role of the CDKN2A locus in patients with multiple primary melanomas J Clin Oncol 23 2005 3043 3051
10. L. Zuo, J. Weger, Q. Yang, A.M. Goldstein, M.A. Tucker, and G.J. Walker et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma Nat Genet 12 1996 97 99
11. E. Nagore, A. Montoro, S. Oltra, E. Ledesma, R. Botella-Estrada, and J.M. Millan et al. Age does not appear to be a major indicator of CDKN2A or CDK4 mutations in melanoma patients in Spain Melanoma Res 15 2005 555 558
12. N. Soufir, M.F. Avril, A. Chompret, F. Demenais, J. Bombled, and A. Spatz et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group Hum Mol Genet 7 1998 209 216
13. N.K. Hayward Genetics of melanoma predisposition Oncogene 22 2003 3053 3062
14. S. Stahl, E. Bar-Meir, E. Friedman, E. Regev, A. Orenstein, and E. Winkler Genetics in Melanoma Ist Med Assoc J 6 2004 774 777 (Pubitemid 39646696)
15. M.A. Tucker, and A.M. Goldstein Melanoma etiology: where are we? Oncogene 22 2003 3042 3052
16. N.F. Box, D.L. Duffy, W. Chen, M. Stark, N.G. Martin, and R.A. Sturm et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations Am J Hum Genet 69 2001 765 773
17. J.F. Flores, G.J. Walker, J.M. Glendening, F.G. Haluska, J.S. Castresana, and M.P. Rubio et al. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma Cancer Res 56 1996 5023 5032
18. A. Ruiz, S. Puig, M. Lynch, T. Castel, and X. Estivill Retention of the CDKN2A locus and low frequency of point mutations in primary and metastatic cutaneous malignant melanoma, Int J. Cancer 76 1998 312 316
19. J.F. Costello, M.S. Berger, H.S. Huang, and W.K. Cavenee Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation Cancer Res 56 1996 2405 2410
20. M. Gonzalez-Zulueta, C.M. Bender, and A.S. Yang et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing Cancer Res 55 1995 4531 4535
21. S. Puig, A. Ruiz, C. Lazaro, T. Castel, M. Lynch, and J. Palou et al. Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene Am J Hum Genet 57 1995 395 402
22. F.A. De Snoo, and N.K. Hayward Cutaneous melanoma susceptibility and progression genes Cancer Letters 230 2005 153 186
23. V.C. Gray-Schopfer, S. Da Rocha Dias, and R. Marais The role of B-RAF in melanoma Cancer and Metastasis Reviews 24 2005 165 183 (Pubitemid 40576070)
24. J.A. Curtin, J. Fridlyand, T. Kageshita, H.N. Patel, K.J. Busam, and H. Kutzner et al. Distinct sets of genetic alterations in melanoma N Engl J Med 353 2005 2135 2147